Latest Lonza News & Updates

See the latest news and media coverage for Lonza. We track all announcements, press releases, and industry mentions in real time, all in one place.

Lonza

Dedicated CDMO serving the healthcare industry

lonza.com

Headquarters: Basel, Switzerland
Founded year: 1897
Company type: Public company
Number of employees: 15,000+

Last updated Today

Latest news about Lonza

In short: Lonza transitioned to a pure-play CDMO by divesting its Capsules & Health Ingredients business and reporting strong Q1 2026 financial performance.

Company announcements

Today Lonza

Lonza publishes restated Half-Year 2025 financials

The restatement reflects Capsules & Health Ingredients as discontinued operations, aligned with Full-Year 2025 reporting.

June 15 Lonza

Lonza grants exclusive license to Antharis Therapeutics for dual-payload ADCs

The target-specific agreement enables Antharis to develop next-generation ADCs for gastrointestinal cancers using Lonza's site-specific ADC technologies.

June 9 Lonza

Lonza appoints Hans Trees as Global Head of Communications

He will join on 1 September 2026, succeeding David Carter, and brings experience from Roche.

June 2 Lonza

Lonza announces enhanced DNA-to-IND biologics development offering

The offering includes early de-risking, accelerated timelines, and new GS Ori-Go vector technology for higher titers.

Media coverage

Today Ticker Report

Lonza Group (OTCMKTS:LZAGY) Shares Gap Up – Here’s Why - Ticker Report

Shares of Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at...

Today boerse.de

Lonza Publishes Restated Half-Year 2025 Financials Reflecting Capsules & Health Ingredients as Discontinued Operations

Lonza Group AG / Key word(s): Miscellaneous Lonza Publishes Restated Half-Year 2025 Financials Reflecting Capsules & Health Ingredients...

Yesterday AD HOC NEWS

Lonza starts the week with sector view, stock compared to Sartorius and Merck

Lonza begins the new trading week without any new company news, but is in focus in the European healthcare sector compared to DACH peers such as Sartorius and Merck.

June 19 Business Wire

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna's Vaccine (mRNA-1273) Against Novel Coronavirus

CAMBRIDGE, Mass. & BASEL, Switzerland--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new...

Never miss news about Lonza

Track Lonza and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Lonza competitors & trending companies

Browse news for competitors to Lonza and other trending companies.